Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?

IJC Heart and Vessels

Volumn 1, Issue , 2013, Pages 22-31

  Thylén, Ingela ^a,b   Moser, Debra K ^c   Chung, Misook L ^c   Miller, Jennifer ^c   Fluur, Christina ^b   Strömberg, Anna ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Clinical Immunology and Transfusion Medicine   (Sweden)

^c UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

Author keywords

Arrhythmias; Attitudes; End of life; Experiences; Implantable cardioverter defibrillator; Patient preferences

Indexed keywords

ADULT; AGED; ARTICLE; CONVULSIVE THERAPY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; TERMINAL CARE; TREATMENT WITHDRAWAL; VERY ELDERLY;

EID: 84892650454     PISSN: 22147632     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijchv.2013.11.001     Document Type: Article

References (31)

1. Lampert R., Hayes D.L., Annas G.J., Farley M.A., Goldstein N.E., Hamilton R.M., et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010, 7:1008-1026. American College of Cardiology, American Geriatrics SocietyAmerican Geriatrics Society, American Academy of Hospice and Palliative MedicineAmerican Academy of Hospice and Palliative Medicine, American Heart AssociationAmerican Heart Association, European Heart Rhythm AssociationEuropean Heart Rhythm Association, Hospice and Palliative Nurses AssociationHospice and Palliative Nurses Association.
2. Padeletti L., Arnar D.O., Boncinelli L., Brachman J., Camm J.A., Daubert J.C., et al. EHRA expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010, 12:1480-1489. European Heart Rhythm Association, Heart Rhythm SocietyHeart Rhythm Society.
3. Goldstein N.E., Bradley E., Zeidman J., Mehta D., Morrison R.S. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol 2009, 54:371-373.
4. Marinskis G., van Erven L. Deactivation of implanted cardioverter defibrillators at the end of life: results of the EHRA study. Europace 2010, 12:1176-1177. EHRA Scientific Initiatives Committee.
5. Kirkpatrick J.N., Gottlieb M., Sehgal P., Patel R., Verdino R.J. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol 2012, 109:91-94.
6. Pedersen S.S., Chaitsing R., Szili-Torok T., Jordaens L., Theuns D.A.M.J. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life. Am J Cardiol 2013, 111:1443-1447.
7. Fluur C., Bolse K., Strömberg A., Thylén I. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues. Heart Lung 2013, 42:202-207.
8. Goldstein N.E., Mehta D., Siddiqui S., Teitelbaum E., Zeidman J., Singson M., et al. That's like an act of suicide. Patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008, 23:7-12.
9. Kapa S., Mueller P.S., Hayes D.L., Asirvatham S.J. Perspectives on withdrawing pacemaker and Implantable Cardioverter Defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010, 85:981-990.
10. Stewart G.C., Weintraub J.R., Pratibhu P.P., Semigran M.J., Camuso J.M., Brooks K., et al. Patients expectations from implantable cardioverter defibrillators to prevent death in heart failure. J Card Fail 2010, 16:106-113.
11. Raphael C.E., Koa-Wing M., Stain N., Wright I., Francis D.P., Kanagaratnam P. Implantable cardioverter defibrillator recipient attitudes towards device deactivation: how much do patients want to know?. PACE 2011, 34:1628-1633.
12. Strachan P.H., Carroll S.L., de Laat S., Schwartz L., Arthur H.M. Patients' perspectives on EOL issues and implantable cardioverter defibrillators. J Palliat Care 2011, 27:6-11.
13. Conelius J. The development, refinement, and psychometric testing of the attitude toward advanced directive survey in implantable cardioverter defibrillator patients. J Cardiovasc Nurs 2013, 28:238-244.
14. Herman D., Stros P., Curila K., Kebza V., Osmancik P. Deactivation of implantable cardioverter defibrillators: results of patient surveys. Europace 2013, 15:963-969.
15. Russo J.E. Deactivation of ICDs at the end of life: A systematic review of clinical practices and provider and patient attitudes. Am J Nurs 2011, 111:26-35.
16. Thylén I., Wenemark M., Fluur C., Strömberg A., Bolse K., Årestedt K. Development and evaluation of the"EOL-ICD Questionnaire" as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator. Eur J Cardiovasc Nurs October 2013, [accepted for publication].
17. EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
18. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
19. Kramer D.B., Buxton A.E., Zimetbaum P.J. Time for a change - a new approach to ICD replacement. N Engl J Med 2012, 26:291-293.
20. Epstein A.E., Dimarco J.P., Ellenbogen K.A., Estes N.A., Freedman R.A., Gettes L.S., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008, 5:e1-e62. American College of Cardiology, American Heart Association Task Force on Practice GuidelinesAmerican Heart Association Task Force on Practice Guidelines, American Association for Thoracic SurgeryAmerican Association for Thoracic Surgery.
21. Dunbar S.B., Dougherty C.M., Sears S.F. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families. A scientific statement from the American Heart Association. Circulation 2012, 126:2146-2172. on behalf of the American Heart Association Council on Cardiovascular Nursing, Council on Clinical CardiologyCouncil on Clinical Cardiology, Council on Cardiovascular Disease in the YoungCouncil on Cardiovascular Disease in the Young.
22. Clark A.M., Jaarsma T., Strachan P., Davidson P.M., Jerke M., Beattie J.M., et al. Effective communication and ethical consent in decisions related to ICDs. Nat Rev Cardiol 2011, 8:1-12.
23. Coventry P.A., Grande G.E., Richards D.A., Todd C.J. Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: a systematic review. Age Ageing 2005, 34:218-227.
24. Goldstein N.E., Lynn J. Trajectory of end-stage heart failure: the influence of technology and implications for policy change. Perspect Biol Med 2006, 49:10-18.
25. Jaarsma T., Beattie J.M., Ryder M., Rutten F.H., McDonagh T., Mohacsi P., et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009, 11:433-443. Advanced Heart Failure Study Group of the HFA of the ESC.
26. Markman M. Implications of cancer managed as a "chronic illness.". Curr Oncol Rep 2011, 13:90-91.
27. Buck H.G., Zambroski C. Upstreaming palliative care for patients with heart failure. J Cardiovasc Nurs 2012, 27:147-153.
28. Mueller P.S., Jenkins S.M., Bramstedt K.A., Hayes D.L. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol 2008, 31:560-568.
29. Crane M., Wittink M., Doukas D. Respecting end-of-life treatment preferences. Am Acad Fam Physician 2005, 72:1263-1270.
30. Goldstein N.E., Lampert R., Bradley E., Lynn J., Krumholz H.M. Management of implantable cardioverter defibrillators in end of life care. Ann Intern Med 2004, 141:835-838.
31. Berger J.T., Gorski M., Cohen T. Advance health planning and treatment. Preferences among recipients of implantable cardioverter defibrillators: an exploratory study. J Clin Ethics 2006, 17:72-78.